Dr Daniel Chapple

Commercial Director

Daniel is a commercial leader with more than 25 years of experience in clinical research and life sciences, dedicated to building strategic partnerships and expanding access to innovative, patient-centred clinical research.

Patrick Ramiah

Director of Clinical Project Delivery and Operational Excellence

Leads clinical project delivery and operational excellence at Richmond Pharmacology, embedding continuous improvement, Lean Six Sigma principles and high-performing processes that support the delivery of quality clinical research.

Dr Lisa Campbell

Director of Regulatory Strategy & Pharmacovigilance

As a former MHRA regulator, Lisa oversees Regulatory Strategy, Medical Writing and Pharmacovigilance Teams and chairs our Expert Regulatory Advisory Board to ensure delivery of high-quality, derisked and regulatory compliant clinical development.

Dr Edward Jackson

Medical Director

Leads Richmond Pharmacology's non-interventional studies, driving the development of real-world evidence capabilities and applying AI-enabled approaches to generate high-quality clinical insights.

Dr Tom Ashdown

Medical Director

Provides medical leadership across early-phase clinical trials, supporting the safe delivery of innovative therapies including gene editing, RNA-targeted medicines and first-in-human studies.

Dr Matej Goricar

Medical Director

Leads one of Richmond Pharmacology's interventional study teams, delivering innovative early- and late-phase clinical trials across advanced therapies and a broad range of therapeutic areas.

Dr Priscilla Ochuba

Associate Medical Director

Priscilla provides medical leadership across Richmond Pharmacology's early-phase clinical trials, ensuring participant safety, clinical excellence and the successful delivery of innovative research.